Option 1 would be my choice as the compliance is a major challenge in the US health industry. Having deep expertise in regulatory compliance solutions for academic medical centers would give Kyruus a competitive advantage.
The company conducted an economic feasibility study that analyzed the costs and benefits of each strategic option, and weighed the pros and cons. For option 1 in the compliance market, Kyruus estimated it would need $4 million to break even but valued the market potential at $50 million.
While becoming the "Bloomberg of physicians" could help rank doctors and support clinical trials, strictly applying Bloomberg's financial analysis model may contradict Kyruus' goal of improving healthcare quality and compliance with regulations. Data and accurate databases are